• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
CardioCell

CardioCell

Breakthrough Cardiovascular Technology

  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Our Stem Cells
    • Manufacturing
    • Quality Control
    • Exclusive License
  • Clinical Trials
    • Overview
    • Chronic Heart Failure
    • Heart Failure in Patients With Left Ventricular Assist Devices
    • Acute Myocardial Infarction
  • News
    • Press Releases
    • Media Coverage
    • Publications
  • Events
  • LinkedIn

News

September 1, 2015

CardioCell Scientific Advisory Board Chair Presents at the Stem Cells & Regenerative Medicine Congress 2015

News Sep 1, 2015 CardioCell Scientific Advisory Board Chair Presents at the Stem Cells & Regenerative Medicine Congress 2015 WASHINGTON, D.C. – STEM CELLS & REGENERATIVE MEDICINE CONGRESS 2015 – Sept. 1, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary

Read More

News,  Press Releases

May 29, 2015

CardioCell developing stem cell therapy for chronic heart failure

News May 29, 2015 CardioCell developing stem cell therapy for chronic heart failure San Diego biotech startup CardioCell seems to be progressing nicely in developing a stem cell-based therapy for chronic heart failure. READ FULL ARTICLE

Read More

Media Coverage

May 27, 2015

Regenerative Medicine & Stem Cell World Congress 2015 – China

Events Regenerative Medicine & Stem Cell World Congress 2015 - China     Nov. 18-20, 2015 BIT Congress Inc. Shanghai, China

Read More

Events

May 22, 2015

AHA Scientific Sessions 2015

Events AHA Scientific Sessions 2015      Nov. 7-11, 2015American Heart Assn.Orlando, Florida

Read More

Events

March 30, 2015

BIO-Europe 2015

Events BIO-Europe 2015      Nov. 2-4, 2015EBD GroupMunich, Germany

Read More

Events

March 12, 2015

CardioCell adds Stony Brook University to sites conducting phase IIa trial

News Mar 12, 2015 CardioCell adds Stony Brook University to sites conducting phase IIa trial CardioCell, a Stemedica Cell Technologies subsidiary that designs allogeneic stem-cell therapies for cardiovascular indications, has expanded patient recruitment to Stony Brook University’s

Read More

Media Coverage,  News

March 10, 2015

CardioCell Adds Stony Brook University to Sites Conducting a Phase IIa Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure

News Mar 10, 2015 CardioCell Adds Stony Brook University to Sites Conducting a Phase IIa Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure STONY BROOK, NEW YORK — March 10, 2015 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that designs

Read More

Press Releases

February 20, 2015

Stem Cells & Regenerative Medicine Congress 2015

Events Stem Cells & Regenerative Medicine Congress 2015    Sept. 2-3, 2015Terrapin HoldingsWashington, D.C.

Read More

Events

  • « Previous Page
  • Page 1
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 12
  • Next Page »

Primary Sidebar

Categories

  • Events
  • Media Coverage
  • News
  • Press Releases
  • Publications

Footer

About Us

  • Overview
  • Board of Directors
  • Scientific Advisory Board

Technology

  • Our Stem Cells
  • Manufacturing
  • Quality Control
  • Exclusive License

Clinical Trials

  • Overview
  • Chronic Heart Failure
  • Heart Failure in Patients With Left Ventricular Assist Devices
  • Acute Myocardial Infarction
<section id="bpfwp_contact_card_widget-1" class="widget widget_bpfwp_contact_card_widget"><div class="widget-wrap"><h3 class="widgettitle widget-title">Contact</h3>
info@stemcardiocell.com
</div></section>

Copyright © 2023 · Business Pro Theme on Genesis Framework · WordPress · Log in